Form4insider filings, from the source

SEC Form 4 · accession 0000919574-18-002742

FENNEC PHARMACEUTICALS INC. · FENC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Jan 27, 2016
Accepted (ET)
Mar 29, 2018 · 4:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001211583

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jan 27, 2016P4,800$1.98A2,022,157ISee footnote
Common StockF3Jan 27, 2016P4,800$1.98A1,496,274D
Common StockF1,F2Jan 28, 2016P4,000$2.10A2,026,157ISee footnote
Common StockF3Jan 28, 2016P4,000$2.10A1,500,274D
Common StockF1,F2Feb 9, 2016P3,000$1.67A2,029,157ISee footnote
Common StockF3Feb 9, 2016P3,000$1.67A1,503,274D
Common StockF1,F2Feb 10, 2016P11,000$1.63A2,040,157ISee footnote
Common StockF3Feb 10, 2016P11,000$1.63A1,514,274D
Common StockF1,F2Feb 11, 2016P10,100$1.67A2,050,257ISee footnote
Common StockF3Feb 11, 2016P10,100$1.67A1,524,374D
Common StockF1,F2Apr 19, 2016P20,000$1.92A2,070,257ISee footnote
Common StockF3Apr 19, 2016P20,000$1.92A1,544,374D
Common StockF1,F2Apr 21, 2016P11,000$2.02A2,081,257ISee footnote
Common StockF3Apr 21, 2016P11,000$2.02A1,555,374D
Common StockF1,F2May 19, 2016P5,000$2.45A2,086,257ISee footnote
Common StockF3May 19, 2016P5,000$2.45A1,560,374D
Common StockF1,F2May 25, 2016P300$2.45A2,086,557ISee footnote
Common StockF3May 25, 2016P300$2.45A1,560,674D
Common StockF1,F2May 26, 2016P2,425$2.36A2,088,982ISee footnote
Common StockF3May 26, 2016P2,425$2.36A1,563,099D
Common StockF1,F2May 31, 2016P15,700$2.59A2,104,682ISee footnote
Common StockF3May 31, 2016P15,700$2.59A1,578,799D
Common StockF1,F2Jul 5, 2016P1,000$2.23A2,105,682ISee footnote
Common StockF3Jul 5, 2016P1,000$2.23A1,579,799D
Common StockF1,F2Jul 29, 2016P7,000$2.30A2,112,682ISee footnote
Common StockF3Jul 29, 2016P7,000$2.30A1,586,799D
Common StockF1,F2Aug 4, 2016P100$2.32A2,112,782ISee footnote
Common StockF3Aug 4, 2016P100$2.32A1,586,899D
Common StockF4holding———192,666D
Common StockF5holding———166,666D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

This is the first part of a Form 4 filing for the reporting persons. There are four parts to this Form 4 filing because of the constraint of a 30 transaction line maximum for tables in a Form 4.